Notch-ligands For Use In Immunotherapy

  • Published: Feb 8, 2006
  • Earliest Priority: Nov 07 1996
  • Family: 36
  • Cited Works: 8
  • Cited by: 0
  • Cites: 3
  • Additional Info: Cited Works Published

The full document isn't yet available to us from the patent office.


The present invention relates to the use of therapeutic compounds in the modification of T-cell, T-cell-antigen presenting cell (APC) interactions and the interactions between pathogenic organisms and immunocompetent cells of a host. In particular it relates to the use of these compounds in the modulation of the interaction between Notch proteins and their ligands and to the use of such compounds in the therapy of conditions such as graft rejection, autoimmunity, allergy, and asthma and infectious diseases.


Information currently unavailable.

CPC Classifications
IPC Classifications
Download PDF
Document Preview
Document History
  • Publication: Feb 8, 2006
  • Application: Nov 6, 1997
    EP EP 05076507 A
  • Priority: Nov 6, 1997
    EP EP 97911353 A
  • Priority: Sep 11, 1997
    GB GB 9719350 A
  • Priority: Jul 24, 1997
    GB GB 9715674 A
  • Priority: Nov 7, 1996
    GB GB 9623236 A

Download Citation

Sign in to the Lens